These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 2992114)
1. Incorporation of some eicosanoic acids into endothelial cells--effect on platelet inhibitory activity and prostacyclin production. Sicard B; Lagarde M Thromb Haemost; 1985 Apr; 53(2):264-7. PubMed ID: 2992114 [TBL] [Abstract][Full Text] [Related]
2. Uptake and effect on arachidonic acid oxygenation of some icosaenoic acids in human platelets. Lagarde M; Drouot B; Guichardant M; Dechavanne M Biomed Biochim Acta; 1984; 43(8-9):S319-22. PubMed ID: 6097236 [TBL] [Abstract][Full Text] [Related]
3. The effect of arachidonic- and eicosapentaenoic acid on the synthesis of prostacyclin-like material in human umbilical vasculature. Dyerberg J; Jørgensen KA Artery; 1980; 8(1):12-7. PubMed ID: 6252872 [TBL] [Abstract][Full Text] [Related]
4. Polyunsaturated fatty acids influence prostanoid synthesis in vascular endothelial cells under hypoxia and reoxygenation. Oudot F; Cordelet C; Sergiel JP; Grynberg A Int J Vitam Nutr Res; 1998; 68(4):263-71. PubMed ID: 9706502 [TBL] [Abstract][Full Text] [Related]
5. Differential effect of SIN-1 on thromboxane and prostacyclin formation in platelets and endothelial cells. Lagarde M; Bordet JC; Croset M J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S95-7. PubMed ID: 2484709 [TBL] [Abstract][Full Text] [Related]
6. In vitro incorporation and metabolism of icosapentaenoic and docosahexaenoic acids in human platelets--effect on aggregation. Croset M; Lagarde M Thromb Haemost; 1986 Aug; 56(1):57-62. PubMed ID: 3022414 [TBL] [Abstract][Full Text] [Related]
7. Eicosapentaenoic acid and prostacyclin production by cultured human endothelial cells. Spector AA; Kaduce TL; Figard PH; Norton KC; Hoak JC; Czervionke RL J Lipid Res; 1983 Dec; 24(12):1595-604. PubMed ID: 6321621 [TBL] [Abstract][Full Text] [Related]
8. Arachidonic acid strongly stimulates prostaglandin I3 (PGI3) production from eicosapentaenoic acid in human endothelial cells. Bordet JC; Guichardant M; Lagarde M Biochem Biophys Res Commun; 1986 Mar; 135(2):403-10. PubMed ID: 3008717 [TBL] [Abstract][Full Text] [Related]
9. Preferential incorporation of eicosanoid precursor fatty acids into human umbilical vein endothelial cell phospholipids. Takayama H; Gimbrone MA; Schafer AI Biochim Biophys Acta; 1987 Dec; 922(3):314-22. PubMed ID: 2825796 [TBL] [Abstract][Full Text] [Related]
10. A new in vitro model for investigation of tumor cell-platelet-endothelial cell interactions and concomitant eicosanoid biosynthesis. Menter DG; Steinert BW; Sloane BF; Taylor JD; Honn KV Cancer Res; 1987 May; 47(9):2425-32. PubMed ID: 3552214 [TBL] [Abstract][Full Text] [Related]
11. The effect of polyunsaturated fatty acids on endothelial cells and their production of prostacyclin, thromboxane and platelet inhibitory activity. Brox JH; Nordøy A Thromb Haemost; 1983 Dec; 50(4):762-7. PubMed ID: 6420921 [TBL] [Abstract][Full Text] [Related]
12. The inhibitory effect of aspirin on human endothelial cells. Nordoy A; Svensson B; Schroeder C; Hoak JC Thromb Haemost; 1978 Aug; 40(1):103-10. PubMed ID: 364762 [TBL] [Abstract][Full Text] [Related]
13. Studies on the incorporation of eicosapentaenoic acid (EPA) into platelet membrane phospholipids and the effects of EPA supplementation on platelet function, skin bleeding time and blood viscosity in man. Greaves M; Woodcock BE; Galloway JH; Preston FE Br J Clin Pract Suppl; 1984; 31():45-8. PubMed ID: 6091721 [No Abstract] [Full Text] [Related]
14. Mechanisms of hemostasis and therapy of thrombosis: new concepts based on the metabolism of arachidonic acid by platelets and endothelial cells. Silver MJ Adv Pharmacol Chemother; 1981; 18():1-47. PubMed ID: 6275687 [No Abstract] [Full Text] [Related]
15. Human pulmonary endothelial cells in culture. Activities of cells from arteries and cells from veins. Johnson AR J Clin Invest; 1980 Apr; 65(4):841-50. PubMed ID: 6987268 [TBL] [Abstract][Full Text] [Related]
16. Mechanism underlying the inhibition of platelet aggregation by eicosapentaenoic acid and its metabolites. Needleman P; Sprecher H; Whitaker MO; Wyche A Adv Prostaglandin Thromboxane Res; 1980; 6():61-8. PubMed ID: 6247894 [No Abstract] [Full Text] [Related]
17. Effects of essential fatty acid deficiency and supplementation with docosahexaenoic acid (DHA; 22:6n-3) on cellular fatty acid compositions and fatty acyl desaturation in a cell culture model. Tocher DR; Dick JR Prostaglandins Leukot Essent Fatty Acids; 2001 Jan; 64(1):11-22. PubMed ID: 11161581 [TBL] [Abstract][Full Text] [Related]
18. Endothelial cells produce a lipoxygenase derived chemo-repellent which influences platelet/endothelial cell interactions--effect of aspirin and salicylate. Buchanan MR; Butt RW; Magas Z; van Ryn J; Hirsh J; Nazir DJ Thromb Haemost; 1985 Jun; 53(3):306-11. PubMed ID: 3931280 [TBL] [Abstract][Full Text] [Related]
19. Platelet inhibitory functions of aortic endothelial cells. Effects of eicosapentaenoic and docosahexaenoic acids. Bénistant C; Achard F; Marcelon G; Lagarde M Atherosclerosis; 1993 Dec; 104(1-2):27-35. PubMed ID: 8141848 [TBL] [Abstract][Full Text] [Related]
20. Effects of dietary fatty acids, prostaglandins and related compounds on the role of platelets in thrombosis. Srivastava KC Biochem Exp Biol; 1980; 16(3):317-38. PubMed ID: 6268128 [No Abstract] [Full Text] [Related] [Next] [New Search]